| Prev Close | 1.47 |
| Open | 1.45 |
| Day Low/High | 1.43 / 1.52 |
| 52 Wk Low/High | 0.90 / 3.45 |
| Volume | 26.79K |
| Avg Volume | 82.90K |
| Exchange | NASDAQ |
| Shares Outstanding | 30.11M |
| Market Cap | 43.38M |
| EPS | -0.50 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Applied DNA Sciences, Inc., (NASDAQ:APDN) ("Applied DNA" or "the Company," NASDAQ: APDN), announced that it has fulfilled an order for the Company's SigNature ® molecular tags to track granular fertilizer...
Applied DNA Sciences, Inc. ("Applied DNA," "the Company," NASDAQ:APDN) today announced its CertainT® platform, ensuring authenticity through the entire supply chain, is featured in global manufacturer of home...
Applied DNA Sciences, Inc. (NASDAQ: APDN) today announced that Dr.
Applied DNA Sciences, Inc. ("Applied DNA," "the company," NASDAQ: APDN) today announced that it is collaborating with American & Efird, (A&E), one of the world's leading manufacturers and distributors of...
Applied DNA Sciences, Inc. (NASDAQ:APDN) announced that its annual meeting of stockholders to be held tomorrow, Tuesday, February 27, 2018, at 10:00am ET, will also be available via teleconference.
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), and ACG have signed a memorandum of understanding (MoU) that will allow ACG to utilize Applied DNA's proven SigNature ® molecular tagging and...
Collaboration to help thwart counterfeits with molecular tagging of capsules
Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), is pleased to announce the receipt of a Notice of Allowance for its U.
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), announced financial results for the fiscal 2018 first quarter ended December 31, 2017.
Applied DNA Sciences, Inc. (NASDAQ: APDN, "Applied DNA," "the Company") announced today that in conjunction with TheraCann International Benchmark Corporation, it has had early success in the tagging and...
Applied DNA Sciences, Inc. (NASDAQ: APDN, "Applied DNA" ), is pleased to report that SigNature DNA evidence has resulted in two new convictions, bringing the company's total to 117.
Applied DNA Sciences, Inc. ("Applied DNA," "the Company," NASDAQ:APDN), today announced that in response to an order from an international cotton gin, the Company will be installing its patent-pending SigNature ®...
Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2018 first quarter ended December 31, 2017 after market close on Thursday, February 8, 2018.
Applied DNA Sciences, Inc. ("Applied DNA," "the Company," NASDAQ:APDN), today announced it is collaborating with GHCL, Limited (listed on NSE and BSE), a global manufacturer of home textiles, and Reliance Industries...
Applied DNA Sciences, Inc. (NASDAQ: APDN, "Applied DNA," "the Company") today announced the signing of an initial two-year, $1 million contract with TheraCann International Benchmark Corporation, ("TheraCann"), a...
Applied DNA Sciences, Inc. (NASDAQ:APDN, "Applied DNA," "the Company") today announced the establishment of a Central DNA Testing Laboratory in Ahmedabad, India providing full forensic authentication services.
Applied DNA Sciences, Inc. (NASDAQ:APDN; "Applied DNA", "the Company"), today announced it will introduce a GeoTyping™ Beta Program, for the month of February, to brands and retailers interested in identifying...
Applied DNA Sciences, Inc. ( NASDAQ: APDN, "Applied DNA"), today announced that SigNature® DNA evidence has helped to convict a member of an Irish organized crime group involved in a Cash in Transit (CiT) robbery.
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), announced financial results for the full fiscal year and quarter ended September 30, 2017.
Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release results for the fourth quarter and fiscal 2017 ended September 30, 2017 after market close on Thursday, December 28, 2017.
Tax cut bill signed into law.
Applied DNA Sciences, Inc. (NASDAQ: APDN; "Applied DNA") today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase an aggregate of 2,735,000 shares of...
Applied DNA Sciences, Inc. (NASDAQ:APDN; "Applied DNA", "the Company"), and Colorcon, Inc.
Applied DNA Sciences, Inc. (NASDAQ: APDN; "Applied DNA") today announced selected preliminary unaudited financial results for the full fiscal year and quarter ended September 30, 2017.
Applied DNA Sciences, Inc. (NASDAQ: APDN; "Applied DNA", "the Company"), today announced the renewal of their contract to provide SigNature ® DNA via Safesolution SmartDNA AB, its Swedish Distributor, to a prestige...
Applied DNA Sciences, Inc. (NASDAQ: APDN; "Applied DNA", "the Company"), today announced that it will introduce DNA-tagged fertilizer to Turkey and countries in West Africa and Asia following strong interest in the...
Applied DNA Sciences, Inc. (NASDAQ: APDN, "Applied DNA"), announced today that Dr.
Applied DNA Sciences, Inc. (NASDAQ: APDN, "Applied DNA", "the Company"), has begun initial Research and Development pilots for the manufacture of DNA for use in DNA-based therapeutics for two companies.
